Tourmaline Bio, Inc.

TRML · NASDAQ
Analyze with AI
6/30/2025
3/31/2025
12/31/2024
9/30/2024
Operating Activities
Net Income-$23-$23-$22-$20
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$2$2$2$2
Change in WC$0$1$2$2
Other Non-Cash$0-$2-$2-$7
Operating Cash Flow-$20-$22-$21-$23
Investing Activities
PP&E Inv.-$0-$0-$0$0
Net Acquisitions$0$0$0$0
Inv. Purchases-$40-$85-$20-$88
Inv. Sales/Matur.$57$111$36$76
Other Inv. Act.$0$0$0$0
Investing Cash Flow$16$26$16-$12
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$0$1$0$0
Stock Repurch.$0-$0-$0-$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$0$0
Financing Cash Flow$0$1-$0-$0
Forex Effect$0$0$0$0
Net Chg. in Cash-$4$5-$5-$35
Supplemental Information
Beg. Cash$36$31$35$70
End Cash$32$36$31$35
Free Cash Flow-$20-$22-$21-$23
Tourmaline Bio, Inc. (TRML) Financial Statements & Key Stats | AlphaPilot